tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Anixa Biosciences Reports Positive Phase 1 Trial Results
PremiumCompany AnnouncementsAnixa Biosciences Reports Positive Phase 1 Trial Results
2M ago
Anixa Biosciences says all primary endpoints met in breast cancer vaccine trial
Premium
The Fly
Anixa Biosciences says all primary endpoints met in breast cancer vaccine trial
2M ago
Anixa Biosciences’ CAR-T therapy granted WHO approval of non-proprietary name
Premium
The Fly
Anixa Biosciences’ CAR-T therapy granted WHO approval of non-proprietary name
3M ago
Anixa announces final results from Phase 1 trial of breast cancer vaccine
PremiumThe FlyAnixa announces final results from Phase 1 trial of breast cancer vaccine
5M ago
Anixa Biosciences: Promising Clinical Progress and Financial Stability Underpin Buy Rating
Premium
Ratings
Anixa Biosciences: Promising Clinical Progress and Financial Stability Underpin Buy Rating
5M ago
Anixa Biosciences files $200M mixed securities shelf
Premium
The Fly
Anixa Biosciences files $200M mixed securities shelf
5M ago
Anixa Biosciences issued additional U.S. patent for CAR-T technology
PremiumThe FlyAnixa Biosciences issued additional U.S. patent for CAR-T technology
6M ago
Anixa Biosciences: Promising Developments and Strong Intellectual Property Bolster Buy Rating
Premium
Ratings
Anixa Biosciences: Promising Developments and Strong Intellectual Property Bolster Buy Rating
7M ago
Anixa plans to begin Phase 2 of breast cancer vaccine trial
Premium
The Fly
Anixa plans to begin Phase 2 of breast cancer vaccine trial
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100